Tau protein as a differential biomarker of tauopathies

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1739, Issue 2, 2005, Pages 179-197

  Sergeant, Nicolas ^a   Delacourte, André ^a   Buée, Luc ^a  

^a INSERM   (France)

Author keywords

Alzheimer's disease; Biomarker; Microtubule associated tau; Physiopathology; Tauopathy

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHATASE; PHOSPHOTRANSFERASE; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEGENERATION; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CELL POPULATION; CHROMOSOME 17; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOWN SYNDROME; FRAGMENTATION REACTION; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; GENETIC LINKAGE; GLIA CELL; HUMAN; MICROTUBULE ASSEMBLY; MISSENSE MUTATION; MOLECULE; MYOTONIC DYSTROPHY; NEOCORTEX; NERVE DEGENERATION; NIEMANN PICK DISEASE; NONHUMAN; OBSERVATION; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; RNA SPLICING; SYMPTOM; TAUOPATHY;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RNA PROCESSING, POST-TRANSCRIPTIONAL; TAU PROTEINS; TAUOPATHIES;

EID: 10944223484     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.06.020     Document Type: Review

References (249)

1. T.A. Schoenfeld, and R.A. Obar Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system Int. Rev. Cytol. 151 1994 67 137
2. R.P. Tucker The roles of microtubule-associated proteins in brain morphogenesis: a review Brain Res. Brain Res. Rev. 15 1990 101 120
3. S.S. Chin, and J.E. Goldman Glial inclusions in CNS degenerative diseases J. Neuropathol. Exp. Neurol. 55 1996 499 508
4. Y. Gu, F. Oyama, and Y. Ihara Tau is widely expressed in rat tissues J. Neurochem. 67 1996 1235 1244
5. M. Ingelson, E. Vanmechelen, and L. Lannfelt Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation Neurosci. Lett. 220 1996 9 12
6. M.T. Vanier, P. Neuville, L. Michalik, and J.F. Launay Expression of specific tau exons in normal and tumoral pancreatic acinar cells J. Cell. Sci. 111 Pt 10 1998 1419 1432
7. R.L. Neve, P. Harris, K.S. Kosik, D.M. Kurnit, and T.A. Donlon Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2 Brain Res. 387 1986 271 280
8. A. Andreadis, J.A. Broderick, and K.S. Kosik Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons Nucleic Acids Res. 23 1995 3585 3593
9. A. Andreadis, B.K. Wagner, J.A. Broderick, and K.S. Kosik A tau promoter region without neuronal specificity J. Neurochem. 66 1996 2257 2263
10. A. Heicklen-Klein, and I. Ginzburg Tau promoter confers neuronal specificity and binds Sp1 and AP-2 J. Neurochem. 75 2000 1408 1418
11. M.L. Wei, and A. Andreadis Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau J. Neurochem. 70 1998 1346 1356
12. M.H. Luo, M.L. Leski, and A. Andreadis Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation J. Cell. Biochem. 91 2004 880 895
13. M. Goedert, M.G. Spillantini, R. Jakes, D. Rutherford, and R.A. Crowther Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 1989 519 526
14. M. Goedert, M.G. Spillantini, M.C. Potier, J. Ulrich, and R.A. Crowther Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain EMBO J. 8 1989 393 399
15. A. Andreadis, W.M. Brown, and K.S. Kosik Structure and novel exons of the human tau gene Biochemistry 31 1992 10626 10633
16. A. Himmler, D. Drechsel, M.W. Kirschner, and D.W. Martin Jr. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains Mol. Cell. Biol. 9 1989 1381 1388
17. K.S. Kosik, L.D. Orecchio, S. Bakalis, and R.L. Neve Developmentally regulated expression of specific tau sequences Neuron 2 1989 1389 1397
18. M. Goedert, and R. Jakes Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization EMBO J. 9 1990 4225 4230
19. M. Goedert, and M.G. Spillantini Molecular neuropathology of Alzheimer's disease: in situ hybridization studies Cell. Mol. Neurobiol. 10 1990 159 174
20. R. Brandt, J. Leger, and G. Lee Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain J. Cell. Biol. 131 1995 1327 1340
21. N. Hirokawa, Y. Shiomura, and S. Okabe Tau proteins: the molecular structure and mode of binding on microtubules J. Cell. Biol. 107 1988 1449 1459
22. A. Harada, K. Oguchi, S. Okabe, J. Kuno, S. Terada, T. Ohshima, R. Sato-Yoshitake, Y. Takei, T. Noda, and N. Hirokawa Altered microtubule organization in small-calibre axons of mice lacking tau protein Nature 369 1994 488 491
23. H.N. Dawson, A. Ferreira, M.V. Eyster, N. Ghoshal, L.I. Binder, and M.P. Vitek Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice J. Cell Sci. 114 2001 1179 1187
24. J. Chen, Y. Kanai, N.J. Cowan, and N. Hirokawa Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons Nature 360 1992 674 677
25. I.S. Georgieff, R.K. Liem, D. Couchie, C. Mavilia, J. Nunez, and M.L. Shelanski Expression of high molecular weight tau in the central and peripheral nervous systems J. Cell. Sci. 105 Pt 3 1993 729 737
26. M.F. Carlier, C. Simon, R. Cassoly, and L.A. Pradel Interaction between microtubule-associated protein tau and spectrin Biochimie 66 1984 305 311
27. I. Correas, R. Padilla, and J. Avila The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding Biochem. J. 269 1990 61 64
28. J.P. Henriquez, D. Cross, C. Vial, and R.B. Maccioni Subpopulations of tau interact with microtubules and actin filaments in various cell types Cell Biochem. Funct. 13 1995 239 250
29. S.C. Selden, and T.D. Pollard Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments J. Biol. Chem. 258 1983 7064 7071
30. Y. Miyata, M. Hoshi, E. Nishida, Y. Minami, and H. Sakai Binding of microtubule-associated protein 2 and tau to the intermediate filament reassembled from neurofilament 70-kDa subunit protein. Its regulation by calmodulin J. Biol. Chem. 261 1986 13026 13030
31. A. Matus Microtubule-associated proteins and the determination of neuronal form J. Physiol. (Paris) 84 1990 134 137
32. D. Jung, D. Filliol, M. Miehe, and A. Rendon Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU Cell Motil. Cytoskelet. 24 1993 245 255
33. G. Lee, R. Thangavel, V.M. Sharma, J.M. Litersky, K. Bhaskar, S.M. Fang, L.H. Do, A. Andreadis, G. Van Hoesen, and H. Ksiezak-Reding Phosphorylation of tau by fyn: implications for Alzheimer's disease J. Neurosci. 24 2004 2304 2312
34. R. Williamson, T. Scales, B.R. Clark, G. Gibb, C.H. Reynolds, S. Kellie, I.N. Bird, I.M. Varndell, P.W. Sheppard, I. Everall, and B.H. Anderton Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases J. Neurosci. 22 2002 10 20
35. S.M. Jenkins, and G.V. Johnson Tau complexes with phospholipase C-gamma in situ NeuroReport 9 1998 67 71
36. S.C. Hwang, D.Y. Jhon, Y.S. Bae, J.H. Kim, and S.G. Rhee Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid J. Biol. Chem. 271 1996 18342 18349
37. G. Lee, R.L. Neve, and K.S. Kosik The microtubule binding domain of tau protein Neuron 2 1989 1615 1624
38. R. Brandt, and G. Lee The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules J. Neurochem. 61 1993 997 1005
39. R. Brandt, and G. Lee Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro J. Biol. Chem. 268 1993 3414 3419
40. D.W. Cleveland, S.Y. Hwo, and M.W. Kirschner Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly J. Mol. Biol. 116 1977 227 247
41. D.W. Cleveland, S.Y. Hwo, and M.W. Kirschner Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin J. Mol. Biol. 116 1977 207 225
42. M.D. Weingarten, A.H. Lockwood, S.Y. Hwo, and M.W. Kirschner A protein factor essential for microtubule assembly Proc. Natl. Acad. Sci. U. S. A. 72 1975 1858 1862
43. D.N. Drechsel, A.A. Hyman, M.H. Cobb, and M.W. Kirschner Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau Mol. Biol. Cell. 3 1992 1141 1154
44. K.A. Butner, and M.W. Kirschner Tau protein binds to microtubules through a flexible array of distributed weak sites J. Cell. Biol. 115 1991 717 730
45. N. Gustke, B. Trinczek, J. Biernat, E.M. Mandelkow, and E. Mandelkow Domains of tau protein and interactions with microtubules Biochemistry 33 1994 9511 9522
46. B.L. Goode, and S.C. Feinstein Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau J. Cell Biol. 124 1994 769 782
47. S. Kar, G.J. Florence, I. Paterson, and L.A. Amos Discodermolide interferes with the binding of tau protein to microtubules FEBS Lett. 539 2003 34 36
48. S. Kar, J. Fan, M.J. Smith, M. Goedert, and L.A. Amos Repeat motifs of tau bind to the insides of microtubules in the absence of taxol EMBO J. 22 2003 70 77
49. E. Sontag, V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret, C.L. White III, M.C. Mumby, and G.S. Bloom Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies J. Biol. Chem. 274 1999 25490 25498
50. R.S. Haltiwanger, S. Busby, K. Grove, S. Li, D. Mason, L. Medina, D. Moloney, G. Philipsberg, and R. Scartozzi O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation? Biochem. Biophys. Res. Commun. 231 1997 237 242
51. L.K. Kreppel, M.A. Blomberg, and G.W. Hart Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats J. Biol. Chem. 272 1997 9308 9315
52. G.W. Hart, L.K. Kreppel, F.I. Comer, C.S. Arnold, D.M. Snow, Z. Ye, X. Cheng, D. DellaManna, D.S. Caine, B.J. Earles, Y. Akimoto, R.N. Cole, and B.K. Hayes O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization Glycobiology 6 1996 711 716
53. K. Kamemura, and G.W. Hart Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription Prog. Nucleic. Acid Res. Mol. Biol. 73 2003 107 136
54. D.L. Dong, Z.S. Xu, G.W. Hart, and D.W. Cleveland Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H J. Biol. Chem. 271 1996 20845 20852
55. T. Lefebvre, M.L. Caillet-Boudin, L. Buee, A. Delacourte, and J.C. Michalski O-GlcNAc glycosylation and neurological disorders Adv. Exp. Med. Biol. 535 2003 189 202
56. T. Lefebvre, S. Ferreira, L. Dupont-Wallois, T. Bussiere, M.J. Dupire, A. Delacourte, J.C. Michalski, and M.L. Caillet-Boudin Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization Biochim. Biophys. Acta 1619 2003 167 176
57. M. Hasegawa, M. Morishima-Kawashima, K. Takio, M. Suzuki, K. Titani, and Y. Ihara Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain J. Biol. Chem. 267 1992 17047 17054
58. M. Hasegawa Phosphorylation in tau protein Seikagaku 65 1993 469 473
59. M. Hasegawa, A. Watanabe, K. Takio, M. Suzuki, T. Arai, K. Titani, and Y. Ihara Characterization of two distinct monoclonal antibodies to paired helical filaments: further evidence for fetal-type phosphorylation of the tau in paired helical filaments J. Neurochem. 60 1993 2068 2077
60. S. Lovestone, and C.H. Reynolds The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes Neuroscience 78 1997 309 324
61. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, A. Watanabe, K. Titani, and Y. Ihara Hyperphosphorylation of tau in PHF Neurobiol. Aging 16 1995 365 371
62. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, and Y. Ihara Proline-directed and non-proline-directed phosphorylation of PHF-tau J. Biol. Chem. 270 1995 823 829
63. L. Buee, T. Bussiere, V. Buee-Scherrer, A. Delacourte, and P.R. Hof Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res. Brain Res. Rev. 33 2000 95 130
64. P. Seubert, M. Mawal-Dewan, R. Barbour, R. Jakes, M. Goedert, G.V. Johnson, J.M. Litersky, D. Schenk, I. Lieberburg, and J.Q. Trojanowski Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau J. Biol. Chem. 270 1995 18917 18922
65. H.M. Roder, R.P. Fracasso, F.J. Hoffman, J.A. Witowsky, G. Davis, and C.B. Pellegrino Phosphorylation-dependent monoclonal Tau antibodies do not reliably report phosphorylation by extracellular signal-regulated kinase 2 at specific sites J. Biol. Chem. 272 1997 4509 4515
66. G. Drewes, B. Lichtenberg-Kraag, F. Doring, E.M. Mandelkow, J. Biernat, J. Goris, M. Doree, and E. Mandelkow Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state EMBO J. 11 1992 2131 2138
67. M. Goedert, M. Hasegawa, R. Jakes, S. Lawler, A. Cuenda, and P. Cohen Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases FEBS Lett. 409 1997 57 62
68. C.H. Reynolds, M.A. Utton, G.M. Gibb, A. Yates, and B.H. Anderton Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein J. Neurochem. 68 1997 1736 1744
69. R. Vulliet, S.M. Halloran, R.K. Braun, A.J. Smith, and G. Lee Proline-directed phosphorylation of human Tau protein J. Biol. Chem. 267 1992 22570 22574
70. M. Takahashi, K. Tomizawa, K. Sato, A. Ohtake, and A. Omori A novel tau-tubulin kinase from bovine brain FEBS Lett. 372 1995 59 64
71. M. Takahashi, K. Tomizawa, K. Ishiguro, M. Takamatsu, S.C. Fujita, and K. Imahori Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain J. Neurochem. 64 1995 1759 1768
72. K. Baumann, E.M. Mandelkow, J. Biernat, H. Piwnica-Worms, and E. Mandelkow Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5 FEBS Lett. 336 1993 417 424
73. W.K. Liu, R.T. Williams, F.L. Hall, D.W. Dickson, and S.H. Yen Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments Am. J. Pathol. 146 1995 228 238
74. S.M. Jenkins, M. Zinnerman, C. Garner, and G.V. Johnson Modulation of tau phosphorylation and intracellular localization by cellular stress Biochem. J. 345 Pt 2 2000 263 270
75. V. Buee-Scherrer, and M. Goedert Phosphorylation of microtubule- associated protein tau by stress-activated protein kinases in intact cells FEBS Lett. 515 2002 151 154
76. G. Drewes, A. Ebneth, U. Preuss, E.M. Mandelkow, and E. Mandelkow MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption Cell 89 1997 297 308
77. 2+/calmodulin-dependent protein kinase II J. Biol. Chem. 263 1988 5876 5883
78. B. Steiner, E.M. Mandelkow, J. Biernat, N. Gustke, H.E. Meyer, B. Schmidt, G. Mieskes, H.D. Soling, D. Drechsel, and M.W. Kirschner Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles EMBO J. 9 1990 3539 3544
79. G.A. Jicha, C. Weaver, E. Lane, C. Vianna, Y. Kress, J. Rockwood, and P. Davies cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease J. Neurosci. 19 1999 7486 7494
80. J.M. Litersky, and G.V. Johnson Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain J. Biol. Chem. 267 1992 1563 1568
81. M. Pierre, and J. Nunez Multisite phosphorylation of tau proteins from rat brain Biochem. Biophys. Res. Commun. 115 1983 212 219
82. J.A. Greenwood, C.W. Scott, R.C. Spreen, C.B. Caputo, and G.V. Johnson Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor J. Biol. Chem. 269 1994 4373 4380
83. E. Planel, X. Sun, and A. Takashima Role of GSK-3beta in Alzheimer's disease pathology Drug Dev. Res. 56 2002 491 510
84. T.J. Singh, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal Non-proline- dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain Mol. Cell. Biochem. 154 1996 143 151
85. Y.L. Woods, P. Cohen, W. Becker, R. Jakes, M. Goedert, X. Wang, and C.G. Proud The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase Biochem. J. 355 2001 609 615
86. V. Buee-Scherrer, O. Condamines, C. Mourton-Gilles, R. Jakes, M. Goedert, B. Pau, and A. Delacourte AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease Brain Res. Mol. Brain Res. 39 1996 79 88
87. N. Sergeant, T. Bussiere, P. Vermersch, J.P. Lejeune, and A. Delacourte Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins NeuroReport 6 1995 2217 2220
88. E.S. Matsuo, R.W. Shin, M.L. Billingsley, A. Van deVoorde, M. O'Connor, J.Q. Trojanowski, and V.M. Lee Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau Neuron 13 1994 989 1002
89. C. Soulie, J. Lepagnol, A. Delacourte, and M.L. Caillet-Boudin Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity Neurosci. Lett. 206 1996 189 192
90. P. Cohen The structure and regulation of protein phosphatases Annu. Rev. Biochem. 58 1989 453 508
91. T.S. Ingebritsen, and P. Cohen The protein phosphatases involved in cellular regulation: 1. Classification and substrate specificities Eur. J. Biochem. 132 1983 255 261
92. S.M. Dudek, and G.V. Johnson Postnatal changes in serine/threonine protein phosphatases and their association with the microtubules Brain Res. Dev. Brain Res. 90 1995 54 61
93. H. Liao, Y. Li, D.L. Brautigan, and G.G. Gundersen Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau J. Biol. Chem. 273 1998 21901 21908
94. M. Goedert, R. Jakes, Z. Qi, J.H. Wang, and P. Cohen Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase J. Neurochem. 65 1995 2804 2807
95. S. Goto, H. Yamamoto, K. Fukunaga, T. Iwasa, Y. Matsukado, and E. Miyamoto Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin J. Neurochem. 45 1985 276 283
96. H. Yamamoto, Y. Saitoh, K. Fukunaga, H. Nishimura, and E. Miyamoto Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly J. Neurochem. 50 1988 1614 1623
97. H. Yamamoto, Y. Saitoh, S. Yasugawa, and E. Miyamoto Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum J. Neurochem. 55 1990 683 690
98. T. Ono, H. Yamamoto, K. Tashima, H. Nakashima, E. Okumura, K. Yamada, S. Hisanaga, T. Kishimoto, T. Miyakawa, and E. Miyamoto Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease Neurochem. Int. 26 1995 205 215
99. T. Saito, K. Ishiguro, T. Uchida, E. Miyamoto, T. Kishimoto, and S. Hisanaga In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons FEBS Lett. 376 1995 238 242
100. C.X. Gong, F. Liu, G. Wu, S. Rossie, J. Wegiel, L. Li, I. Grundke-Iqbal, and K. Iqbal Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5 J. Neurochem. 88 2004 298 310
101. J. Biernat, N. Gustke, G. Drewes, E.M. Mandelkow, and E. Mandelkow Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding Neuron 11 1993 153 163
102. G.T. Bramblett, M. Goedert, R. Jakes, S.E. Merrick, J.Q. Trojanowski, and V.M. Lee Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 10 1993 1089 1099
103. D. Drubin, S. Kobayashi, and M. Kirschner Association of tau protein with microtubules in living cells Ann. N. Y. Acad. Sci. 466 1986 257 268
104. G. Lindwall, and R.D. Cole Phosphorylation affects the ability of tau protein to promote microtubule assembly J. Biol. Chem. 259 1984 5301 5305
105. B.L. Goode, P.E. Denis, D. Panda, M.J. Radeke, H.P. Miller, L. Wilson, and S.C. Feinstein Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly Mol. Biol. Cell. 8 1997 353 365
106. M. Hasegawa, R. Jakes, R.A. Crowther, V.M. Lee, Y. Ihara, and M. Goedert Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein FEBS Lett. 384 1996 25 30
107. T. Bussiere, P.R. Hof, C. Mailliot, C.D. Brown, M.L. Caillet-Boudin, D.P. Perl, L. Buee, and A. Delacourte Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration Acta Neuropathol. (Berl.) 97 1999 221 230
108. R. Hoffmann, V.M. Lee, S. Leight, I. Varga, and L. Otvos Jr. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites Biochemistry 36 1997 8114 8124
109. I. Vincent, M. Rosado, and P. Davies Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132 1996 413 425
110. A. Delacourte, and L. Buee Normal and pathological Tau proteins as factors for microtubule assembly Int. Rev. Cytol. 171 1997 167 224
111. V. Zhukareva, V. Vogelsberg-Ragaglia, V.M. Van Deerlin, J. Bruce, T. Shuck, M. Grossman, C.M. Clark, S.E. Arnold, E. Masliah, D. Galasko, J.Q. Trojanowski, and V.M. Lee Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia Ann. Neurol. 49 2001 165 175
112. V. Zhukareva, S. Sundarraj, D. Mann, M. Sjogren, K. Blenow, C.M. Clark, D.W. McKeel, A. Goate, C.F. Lippa, J.P. Vonsattel, J.H. Growdon, J.Q. Trojanowski, and V.M. Lee Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study Acta Neuropathol. (Berl.) 105 2003 469 476
113. N. Sergeant, J.P. David, M. Goedert, R. Jakes, P. Vermersch, L. Buee, D. Lefranc, A. Wattez, and A. Delacourte Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications J. Neurochem. 69 1997 834 844
114. M. Goedert, M.G. Spillantini, N.J. Cairns, and R.A. Crowther Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms Neuron 8 1992 159 168
115. P.R. Hof, C. Bouras, L. Buee, A. Delacourte, D.P. Perl, and J.H. Morrison Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases Acta Neuropathol. (Berl.) 85 1992 23 30
116. P.R. Hof, A. Charpiot, A. Delacourte, L. Buee, D. Purohit, D.P. Perl, and C. Bouras Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism Neurosci. Lett. 139 1992 10 14
117. V. Buee-Scherrer, L. Buee, P.R. Hof, B. Leveugle, C. Gilles, A.J. Loerzel, D.P. Perl, and A. Delacourte Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins Am. J. Pathol. 146 1995 924 932
118. V. Buee-Scherrer, L. Buee, B. Leveugle, D.P. Perl, P. Vermersch, P.R. Hof, and A. Delacourte Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders Ann. Neurol. 42 1997 356 359
119. A. Delacourte, and L. Buee Tau pathology: a marker of neurodegenerative disorders Curr. Opin. Neurol. 13 2000 371 376
120. D. Caparros-Lefebvre, N. Sergeant, A. Lees, A. Camuzat, S. Daniel, A. Lannuzel, A. Brice, E. Tolosa, A. Delacourte, and C. Duyckaerts Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy Brain 125 2002 801 811
121. A. Delacourte, N. Sergeant, A. Wattez, C.A. Maurage, F. Lebert, F. Pasquier, and J.P. David Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp. Gerontol. 37 2002 1291 1296
122. S. Love, L.R. Bridges, and C.P. Case Neurofibrillary tangles in Niemann-Pick disease type C Brain 118 Pt 1 1995 119 129
123. M.G. Spillantini, M. Tolnay, S. Love, and M. Goedert Microtubule- associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia Acta Neuropathol. (Berl) 97 1999 585 594
124. T. Revesz, J.L. Holton, B. Doshi, B.H. Anderton, F. Scaravilli, and G.T. Plant Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation Acta Neuropathol. (Berl). 97 1999 170 176
125. J.L. Holton, J. Ghiso, T. Lashley, A. Rostagno, C.J. Guerin, G. Gibb, H. Houlden, H. Ayling, L. Martinian, B.H. Anderton, N.W. Wood, R. Vidal, G. Plant, B. Frangione, and T. Revesz Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia Am. J. Pathol. 158 2001 515 526
126. N. Sergeant, A. Wattez, and A. Delacourte Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms J. Neurochem. 72 1999 1243 1249
127. S. Flament, A. Delacourte, M. Verny, J.J. Hauw, and F. Javoy-Agid Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type Acta Neuropathol. (Berl.) 81 1991 591 596
128. M. Tolnay, N. Sergeant, A. Ghestem, S. Chalbot, R.A. De Vos, E.N. Jansen Steur, A. Probst, and A. Delacourte Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms Acta Neuropathol. (Berl). 104 2002 425 434
129. M. Tolnay, M.G. Spillantini, M. Goedert, J. Ulrich, D. Langui, and A. Probst Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons Acta Neuropathol. (Berl.) 93 1997 477 484
130. J.C. Steele, J.C. Richardson, and J. Olszewski Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia Arch. Neurol. 10 1964 333 359
131. J.C. Richardson, J. Steele, and J. Olszewski Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogeneous system degeneration" Trans. Am. Neurol. Assoc. 88 1963 25 29
132. I. Litvan, and M. Hutton Clinical and genetic aspects of progressive supranuclear palsy J. Geriatr. Psychiatry Neurol. 11 1998 107 114
133. I. Litvan Diagnosis and management of progressive supranuclear palsy Semin. Neurol. 21 2001 41 48
134. J.J. Hauw, M. Verny, P. Delaere, P. Cervera, Y. He, and C. Duyckaerts Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging Neurosci. Lett. 119 1990 182 186
135. P.R. Hof, A. Delacourte, and C. Bouras Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases Acta Neuropathol. (Berl.) 84 1992 45 51
136. C. Bergeron, M.S. Pollanen, L. Weyer, and A.E. Lang Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration J. Neuropathol. Exp. Neurol. 56 1997 726 734
137. M. Verny, K.A. Jellinger, J.J. Hauw, C. Bancher, I. Litvan, and Y. Agid Progressive supranuclear palsy: a clinicopathological study of 21 cases Acta Neuropathol. (Berl.) 91 1996 427 431
138. M. Verny, C. Duyckaerts, Y. Agid, and J.J. Hauw The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases Brain 119 Pt 4 1996 1123 1136
139. T. Komori Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease Brain Pathol. 9 1999 663 679
140. T. Komori, N. Arai, M. Oda, H. Nakayama, H. Mori, S. Yagishita, T. Takahashi, N. Amano, S. Murayama, S. Murakami, N. Shibata, M. Kobayashi, S. Sasaki, and M. Iwata Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy Acta Neuropathol. (Berl.) 96 1998 401 408
141. J.J. Rebeiz, E.H. Kolodny, and E.P. Richardson Jr. Corticodentatonigral degeneration with neuronal achromasia Arch. Neurol. 18 1968 20 33
142. J.J. Rebeiz, E.H. Kolodny, and E.P. Richardson Jr. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life Trans. Am. Neurol. Assoc. 92 1967 23 26
143. J.O. Rinne, M.S. Lee, P.D. Thompson, and C.D. Marsden Corticobasal degeneration. A clinical study of 36 cases Brain 117 Pt 5 1994 1183 1196
144. I. Litvan, Y. Agid, C. Goetz, J. Jankovic, G.K. Wenning, J.P. Brandel, E.C. Lai, M. Verny, K. Ray-Chaudhuri, A. McKee, K. Jellinger, R.K. Pearce, and J.J. Bartko Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study Neurology 48 1997 119 125
145. I. Litvan, J.L. Cummings, and M. Mega Neuropsychiatric features of corticobasal degeneration J. Neurol. Neurosurg. Psychiatry 65 1998 717 721
146. H. Braak, and E. Braak Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes Neurosci. Lett. 76 1987 124 127
147. H. Braak, and E. Braak Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria J. Neural Transm. 105 1998 801 819
148. H. Braak, and E. Braak Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia Neuropathol. Appl. Neurobiol. 15 1989 13 26
149. M. Tolnay, M. Schwietert, A.U. Monsch, H.B. Staehelin, D. Langui, and A. Probst Argyrophilic grain disease: distribution of grains in patients with and without dementia Acta Neuropathol. (Berl.) 94 1997 353 358
150. T. Togo, N. Sahara, S.H. Yen, N. Cookson, T. Ishizawa, M. Hutton, R. de Silva, A. Lees, and D.W. Dickson Argyrophilic grain disease is a sporadic 4-repeat tauopathy J. Neuropathol. Exp. Neurol. 61 2002 547 556
151. C.A. Maurage, N. Sergeant, S. Schraen-Maschke, F. Lebert, M.M. Ruchoux, B. Sablonniere, F. Pasquier, and A. Delacourte Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease Acta Neuropathol. (Berl.) 106 2003 575 583
152. P. Mattila, T. Togo, and D.W. Dickson The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease Neurosci. Lett. 320 2002 81 85
153. M. Hutton Molecular genetics of chromosome 17 tauopathies Ann. N. Y. Acad. Sci. 920 2000 63 73
154. M. Baker, I. Litvan, H. Houlden, J. Adamson, D. Dickson, J. Perez-Tur, J. Hardy, T. Lynch, E. Bigio, and M. Hutton Association of an extended haplotype in the tau gene with progressive supranuclear palsy Hum. Mol. Genet. 8 1999 711 715
155. H. Houlden, M. Baker, H.R. Morris, N. MacDonald, S. Pickering-Brown, J. Adamson, A.J. Lees, M.N. Rossor, N.P. Quinn, A. Kertesz, M.N. Khan, J. Hardy, P.L. Lantos, P. St George-Hyslop, D.G. Munoz, D. Mann, A.E. Lang, C. Bergeron, E.H. Bigio, I. Litvan, K.P. Bhatia, D. Dickson, N.W. Wood, and M. Hutton Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype Neurology 56 2001 1702 1706
156. T. Ishizawa, L.W. Ko, N. Cookson, P. Davias, M. Espinoza, and D.W. Dickson Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies J. Neuropathol. Exp. Neurol. 61 2002 1040 1047
157. A.R. Miserez, F. Clavaguera, A.U. Monsch, A. Probst, and M. Tolnay Argyrophilic grain disease: molecular genetic difference to other four-repeat tauopathies Acta Neuropathol. (Berl.) 106 2003 363 366
158. S. Brion, J. Plas, and A. Jeanneau Pick's disease. Anatomo-clinical point of view Rev. Neurol. (Paris) 147 1991 693 704
159. V. Buee Scherrer, P.R. Hof, L. Buee, B. Leveugle, P. Vermersch, D.P.
160. A. Delacourte, Y. Robitaille, N. Sergeant, L. Buee, P.R. Hof, A. Wattez, A. Laroche-Cholette, J. Mathieu, P. Chagnon, and D. Gauvreau Specific pathological Tau protein variants characterize Pick's disease J. Neuropathol. Exp. Neurol. 55 1996 159 168
161. P.R. Hof, C. Bouras, D.P. Perl, and J.H. Morrison Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease Acta Neuropathol. (Berl.) 87 1994 115 124
162. N. Sergeant, J.P. David, D. Lefranc, P. Vermersch, A. Wattez, and A. Delacourte Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases FEBS Lett. 412 1997 578 582
163. A. Delacourte, N. Sergeant, A. Wattez, D. Gauvreau, and Y. Robitaille Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation Ann. Neurol. 43 1998 193 204
164. A. Probst, M. Tolnay, D. Langui, M. Goedert, and M.G. Spillantini Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment Acta Neuropathol. (Berl.) 92 1996 588 596
165. C. Mailliot, N. Sergeant, T. Bussiere, M.L. Caillet-Boudin, A. Delacourte, and L. Buee Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes FEBS Lett. 433 1998 201 204
166. P.S. Harper, and W. Reardon Heart disease in myotonic dystrophy Lancet 339 1992 939
167. W. Reardon, and P.S. Harper Advances in myotonic dystrophy: a clinical and genetic perspective Curr. Opin. Neurol. Neurosurg. 5 1992 605 609
168. G. Meola Clinical and genetic heterogeneity in myotonic dystrophies Muscle Nerve 23 2000 1789 1799
169. G. Meola Myotonic dystrophies Curr. Opin. Neurol. 13 2000 519 525
170. B. Udd, G. Meola, R. Krahe, C. Thornton, L. Ranum, J. Day, G. Bassez, and K. Ricker Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands Neuromuscul. Disord. vol. 13 2003 589 596
171. K. Ricker, M.C. Koch, F. Lehmann-Horn, D. Pongratz, M. Otto, R. Heine, and R.T. Moxley III Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts Neurology 44 1994 1448 1452
172. G. Meola, V. Sansone, S. Radice, S. Skradski, and L. Ptacek A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies Neuromuscul. Disord. 6 1996 143 150
173. C.L. Liquori, K. Ricker, M.L. Moseley, J.F. Jacobsen, W. Kress, S.L. Naylor, J.W. Day, and L.P. Ranum Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9 Science 293 2001 864 867
174. J.D. Brook, M.E. McCurrach, H.G. Harley, A.J. Buckler, D. Church, H. Aburatani, K. Hunter, V.P. Stanton, J.P. Thirion, and T. Hudson Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member Cell 69 1992 385
175. L.P. Ranum, P.F. Rasmussen, K.A. Benzow, M.D. Koob, and J.W. Day Genetic mapping of a second myotonic dystrophy locus Nat. Genet. 19 1998 196 198
176. A. Mankodi, and C.A. Thornton Myotonic syndromes Curr. Opin. Neurol. 15 2002 545 552
177. G. Meola, V. Sansone, D. Perani, A. Colleluori, S. Cappa, M. Cotelli, F. Fazio, C.A. Thornton, and R.T. Moxley Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy Neurology 53 1999 1042 1050
178. G. Meola, V. Sansone, D. Perani, S. Scarone, S. Cappa, C. Dragoni, E. Cattaneo, M. Cotelli, C. Gobbo, F. Fazio, G. Siciliano, M. Mancuso, E. Vitelli, S. Zhang, R. Krahe, and R.T. Moxley Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2) Neuromuscul. Disord. 13 2003 813 821
179. P. Vermersch, N. Sergeant, M.M. Ruchoux, H. Hofmann-Radvanyi, A. Wattez, H. Petit, P. Dwailly, and A. Delacourte Specific tau variants in the brains of patients with myotonic dystrophy Neurology 47 1996 711 717
180. N. Yoshimura Alzheimer's neurofibrillary changes in the olfactory bulb in myotonic dystrophy Clin. Neuropathol. 9 1990 240 243
181. N. Yoshimura, M. Otake, K. Igarashi, M. Matsunaga, K. Takebe, and H. Kudo Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy Clin. Neuropathol. 9 1990 234 239
182. N. Sergeant, B. Sablonniere, S. Schraen-Maschke, A. Ghestem, C.A. Maurage, A. Wattez, P. Vermersch, and A. Delacourte Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1 Hum. Mol. Genet. 10 2001 2143 2155
183. H. Seznec, O. Agbulut, N. Sergeant, C. Savouret, A. Ghestem, N. Tabti, J.C. Willer, L. Ourth, C. Duros, E. Brisson, C. Fouquet, G. Butler-Browne, A. Delacourte, C. Junien, and G. Gourdon Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities Hum. Mol. Genet. 10 2001 2717 2726
184. J. Constantinidis, J. Richard, and R. Tissot Pick's disease. Histological and clinical correlations Eur. Neurol. 11 1974 208 217
185. The Lund and Manchester Groups Clinical and neuropathological criteria for frontotemporal dementia J. Neurol. Neurosurg. Psychiatry 57 1994 416 418
186. J. Brown Pick's disease Baillieres Clin. Neurol. 1 1992 535 557
187. K.C. Wilhelmsen, T. Lynch, E. Pavlou, M. Higgins, and T.G. Nygaard Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22 Am. J. Hum. Genet. 55 1994 1159 1165
188. T.D. Bird, E.M. Wijsman, D. Nochlin, M. Leehey, S.M. Sumi, H. Payami, P. Poorkaj, E. Nemens, M. Rafkind, and G.D. Schellenberg Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD Neurology 48 1997 949 954
189. P. Heutink, M. Stevens, P. Rizzu, E. Bakker, J.M. Kros, A. Tibben, M.F. Niermeijer, C.M. van Duijn, B.A. Oostra, and J.C. van Swieten Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families Ann. Neurol. 41 1997 150 159
190. J.R. Murrell, D. Koller, T. Foroud, M. Goedert, M.G. Spillantini, H.J. Edenberg, M.R. Farlow, and B. Ghetti Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17 Am. J. Hum. Genet. 61 1997 1131 1138
191. M. Wijker, Z.K. Wszolek, E.C. Wolters, M.A. Rooimans, G. Pals, R.F. Pfeiffer, T. Lynch, R.L. Rodnitzky, K.C. Wilhelmsen, and F. Arwert Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21 Hum. Mol. Genet. 5 1996 151 154
192. N.L. Foster, K. Wilhelmsen, A.A. Sima, M.Z. Jones, C.J. D'Amato, and S. Gilman Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference Conf. Particip., Ann. Neurol. 41 1997 706 715
193. M.G. Spillantini, M. Goedert, R.A. Crowther, J.R. Murrell, M.R. Farlow, and B. Ghetti Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments Proc. Natl. Acad. Sci. U. S. A. 94 1997 4113 4118
194. M.G. Spillantini, T.D. Bird, and B. Ghetti Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies Brain Pathol. 8 1998 387 402
195. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R.C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J.M. Kwon, P. Nowotny, and P. Heutink Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
196. A. Grover, H. Houlden, M. Baker, J. Adamson, J. Lewis, G. Prihar, S. Pickering-Brown, K. Duff, and M. Hutton 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10 J. Biol. Chem. 274 1999 15134 15143
197. P. Poorkaj, T.D. Bird, E. Wijsman, E. Nemens, R.M. Garruto, L. Anderson, A. Andreadis, W.C. Wiederholt, M. Raskind, and G.D. Schellenberg Tau is a candidate gene for chromosome 17 frontotemporal dementia Ann. Neurol. 43 1998 815 825
198. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, and B. Ghetti Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc. Natl. Acad. Sci U. S. A. 95 1998 7737 7741
199. S. Hayashi, Y. Toyoshima, M. Hasegawa, Y. Umeda, K. Wakabayashi, S. Tokiguchi, T. Iwatsubo, and H. Takahashi Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation Ann. Neurol. 51 2002 525 530
200. P. Poorkaj, N.A. Muma, V. Zhukareva, E.J. Cochran, K.M. Shannon, H. Hurtig, W.C. Koller, T.D. Bird, J.Q. Trojanowski, V.M. Lee, and G.D. Schellenberg An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype Ann. Neurol. 52 2002 511 516
201. S. Pickering-Brown, M. Baker, S.H. Yen, W.K. Liu, M. Hasegawa, N. Cairns, P.L. Lantos, M. Rossor, T. Iwatsubo, Y. Davies, D. Allsop, R. Furlong, F. Owen, J. Hardy, D. Mann, and M. Hutton Pick's disease is associated with mutations in the tau gene Ann. Neurol. 48 2000 859 867
202. C. Rizzini, M. Goedert, J.R. Hodges, M.J. Smith, R. Jakes, R. Hills, J.H. Xuereb, R.A. Crowther, and M.G. Spillantini Tau gene mutation K257T causes a tauopathy similar to Pick's disease J. Neuropathol. Exp. Neurol. 59 2000 990 1001
203. A. Grover, E. England, M. Baker, N. Sahara, J. Adamson, B. Granger, H. Houlden, U. Passant, S.H. Yen, M. DeTure, and M. Hutton A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy Exp. Neurol. 184 2003 131 140
204. T. Kobayashi, S. Ota, K. Tanaka, Y. Ito, M. Hasegawa, Y. Umeda, Y. Motoi, M. Takanashi, M. Yasuhara, M. Anno, Y. Mizuno, and H. Mori A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology Ann. Neurol. 53 2003 133 137
205. M. Hogg, Z.M. Grujic, M. Baker, S. Demirci, A.L. Guillozet, A.P. Sweet, L.L. Herzog, S. Weintraub, M.M. Mesulam, N.E. LaPointe, T.C. Gamblin, R.W. Berry, L.I. Binder, R. de Silva, A. Lees, M. Espinoza, P. Davies, A. Grover, N. Sahara, T. Ishizawa, D. Dickson, S.H. Yen, M. Hutton, and E.H. Bigio The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy Acta Neuropathol. (Berl.) 106 2003 323 336
206. S.M. Rosso, L. Donker Kaat, T. Baks, M. Joosse, I. de Koning, Y. Pijnenburg, D. de Jong, D. Dooijes, W. Kamphorst, R. Ravid, M.F. Niermeijer, F. Verheij, H.P. Kremer, P. Scheltens, C.M. van Duijn, P. Heutink, and J.C. van Swieten Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study Brain 126 2003 2016 2022
207. M.B. Delisle, J.R. Murrell, R. Richardson, J.A. Trofatter, O. Rascol, X. Soulages, M. Mohr, P. Calvas, and B. Ghetti A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy Acta Neuropathol. (Berl.) 98 1999 62 77
208. M. Hasegawa, M.J. Smith, M. Iijima, T. Tabira, and M. Goedert FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10 FEBS Lett. 443 1999 93 96
209. M. Yasuda, T. Kawamata, O. Komure, S. Kuno, I. D'Souza, P. Poorkaj, J. Kawai, S. Tanimukai, Y. Yamamoto, H. Hasegawa, M. Sasahara, F. Hazama, G.D. Schellenberg, and C. Tanaka A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration Neurology 53 1999 864 868
210. Z.K. Wszolek, Y. Tsuboi, R.J. Uitti, and L. Reed Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene Neurology 55 2000 1939
211. E. Iseki, T. Matsumura, W. Marui, H. Hino, T. Odawara, N. Sugiyama, K. Suzuki, H. Sawada, T. Arai, and K. Kosaka Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells Acta Neuropathol. (Berl.) 102 2001 285 292
212. H. Yoshida, R.A. Crowther, and M. Goedert Functional effects of tau gene mutations deltaN296 and N296H J. Neurochem. 80 2002 548 551
213. C. Dumanchin, A. Camuzat, D. Campion, P. Verpillat, D. Hannequin, B. Dubois, P. Saugier-Veber, C. Martin, C. Penet, F. Charbonnier, Y. Agid, T. Frebourg, and A. Brice Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism Hum. Mol. Genet. 7 1998 1825 1829
214. P. Poorkaj, M. Grossman, E. Steinbart, H. Payami, A. Sadovnick, D. Nochlin, T. Tabira, J.Q. Trojanowski, S. Borson, D. Galasko, S. Reich, B. Quinn, G. Schellenberg, and T.D. Bird Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia Arch. Neurol. 58 2001 383 387
215. O. Bugiani, J.R. Murrell, G. Giaccone, M. Hasegawa, G. Ghigo, M. Tabaton, M. Morbin, A. Primavera, F. Carella, C. Solaro, M. Grisoli, M. Savoiardo, M.G. Spillantini, F. Tagliavini, M. Goedert, and B. Ghetti Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau J. Neuropathol. Exp. Neurol. 58 1999 667 677
216. A.D. Sperfeld, M.B. Collatz, H. Baier, M. Palmbach, A. Storch, J. Schwarz, K. Tatsch, S. Reske, M. Joosse, P. Heutink, and A.C. Ludolph FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation Ann. Neurol. 46 1999 708 715
217. M. Iijima, T. Tabira, P. Poorkaj, G.D. Schellenberg, J.Q. Trojanowski, V.M. Lee, M.L. Schmidt, K. Takahashi, T. Nabika, T. Matsumoto, Y. Yamashita, S. Yoshioka, and H. Ishino A distinct familial presenile dementia with a novel missense mutation in the tau gene NeuroReport 10 1999 497 501
218. S.M. Pickering-Brown, M. Baker, T. Nonaka, K. Ikeda, S. Sharma, J. Mackenzie, S.A. Simpson, J.W. Moore, J.S. Snowden, R. Silva Rd, T. Revesz, M. Hasegawa, M. Hutton, and D.M. Mann Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene Brain 2004
219. M. Hasegawa, M.J. Smith, and M. Goedert Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly FEBS Lett. 437 1998 207 210
220. M. Neumann, W. Schulz-Schaeffer, R.A. Crowther, M.J. Smith, M.G. Spillantini, M. Goedert, and H.A. Kretzschmar Pick's disease associated with the novel Tau gene mutation K369I Ann. Neurol. 50 2001 503 513
221. J.R. Murrell, M.G. Spillantini, P. Zolo, M. Guazzelli, M.J. Smith, M. Hasegawa, F. Redi, R.A. Crowther, P. Pietrini, B. Ghetti, and M. Goedert Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits J. Neuropathol. Exp. Neurol. 58 1999 1207 1226
222. I. D'Souza, P. Poorkaj, M. Hong, D. Nochlin, V.M. Lee, T.D. Bird, and G.D. Schellenberg Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements Proc. Natl. Acad. Sci. U.S.A. 96 1999 5598 5603
223. M.G. Spillantini, J.C. Van Swieten, and M. Goedert Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) Neurogenetics 2 2000 193 205
224. P.M. Stanford, G.M. Halliday, W.S. Brooks, J.B. Kwok, C.E. Storey, H. Creasey, J.G. Morris, M.J. Fulham, and P.R. Schofield Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations Brain 123 Pt 5 2000 880 893
225. P. Rizzu, J.C. Van Swieten, M. Joosse, M. Hasegawa, M. Stevens, A. Tibben, M.F. Niermeijer, M. Hillebrand, R. Ravid, B.A. Oostra, M. Goedert, C.M. van Duijn, and P. Heutink High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands Am. J. Hum. Genet. 64 1999 414 421
226. R. Oliva, and P. Pastor Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy Ann Neurol. 55 2004 448 449
227. M. Goedert, M.G. Spillantini, R.A. Crowther, S.G. Chen, P. Parchi, M. Tabaton, D.J. Lanska, W.R. Markesbery, K.C. Wilhelmsen, D.W. Dickson, R.B. Petersen, and P. Gambetti Tau gene mutation in familial progressive subcortical gliosis Nat. Med. 5 1999 454 457
228. L. Varani, M. Hasegawa, M.G. Spillantini, M.J. Smith, J.R. Murrell, B. Ghetti, A. Klug, M. Goedert, and G. Varani Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17 Proc. Natl. Acad. Sci. U. S. A. 96 1999 8229 8234
229. M. Hong, V. Zhukareva, V. Vogelsberg-Ragaglia, Z. Wszolek, L. Reed, B.I. Miller, D.H. Geschwind, T.D. Bird, D. McKeel, A. Goate, J.C. Morris, K.C. Wilhelmsen, G.D. Schellenberg, J.Q. Trojanowski, and V.M. Lee Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17 Science 282 1998 1914 1917
230. L.A. Reed, M.L. Schmidt, Z.K. Wszolek, B.J. Balin, V. Soontornniyomkij, V.M. Lee, J.Q. Trojanowski, and R.L. Schelper The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto- nigral degeneration") J. Neuropathol. Exp. Neurol. 57 1998 588 601
231. S. Yen, C. Easson, P. Nacharaju, M. Hutton, and S.H. Yen FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion FEBS Lett. 461 1999 91 95
232. R. Dayanandan, M. Van Slegtenhorst, T.G. Mack, L. Ko, S.H. Yen, K. Leroy, J.P. Brion, B.H. Anderton, M. Hutton, and S. Lovestone Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation FEBS Lett. 446 1999 228 232
233. F. Chiti, M. Stefani, N. Taddei, G. Ramponi, and C.M. Dobson Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
234. P. Delobel, S. Flament, M. Hamdane, R. Jakes, A. Rousseau, A. Delacourte, J.P. Vilain, M. Goedert, and L. Buee Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation J. Biol. Chem. 277 2002 9199 9205
235. A. Delacourte, J.P. David, N. Sergeant, L. Buee, A. Wattez, P. Vermersch, F. Ghozali, C. Fallet-Bianco, F. Pasquier, F. Lebert, H. Petit, and C. Di Menza The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease Neurology 52 1999 1158 1165
236. G. Roks, B. Dermaut, P. Heutink, A. Julliams, H. Backhovens, M. Van de Broeck, S. Serneels, A. Hofman, C. Van Broeckhoven, C.M. van Duijn, and M. Cruts Mutation screening of the tau gene in patients with early-onset Alzheimer's disease Neurosci. Lett. 277 1999 137 139
237. F. Crawford, M. Freeman, T. Town, D. Fallin, M. Gold, R. Duara, and M. Mullan No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples Neurosci. Lett. 266 1999 193 196
238. C. Russ, J.F. Powell, J. Zhao, M. Baker, M. Hutton, F. Crawford, M. Mullan, G. Roks, M. Cruts, and S. Lovestone The microtubule associated protein Tau gene and Alzheimer's disease-an association study and meta-analysis Neurosci. Lett. 314 2001 92 96
239. E.S. Athan, J.H. Lee, A. Arriaga, R.P. Mayeux, and B. Tycko Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease Arch. Neurol. 59 2002 1793 1799
240. A. Rocchi, S. Pellegrini, G. Siciliano, and L. Murri Causative and susceptibility genes for Alzheimer's disease: a review Brain Res. Bull. 61 2003 1 24
241. S. Sorbi, B. Nacmias, A. Tedde, P. Forleo, S. Piacentini, S. Latorraca, and L. Amaducci Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease Neurosci. Lett. 222 1997 132 134
242. J.C. Lambert, J. Perez-Tur, M.J. Dupire, D. Galasko, D. Mann, P. Amouyel, J. Hardy, A. Delacourte, and M.C. Chartier-Harlin Distortion of allelic expression of apolipoprotein E in Alzheimer's disease Hum. Mol. Genet. 6 1997 2151 2154
243. M.C. Chartier-Harlin, L. Araria-Goumidi, and J.C. Lambert Genetic complexity of Alzheimer's disease Rev. Neurol. (Paris) 160 2004 251 255
244. Y.H. Suh, and F. Checler Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease Pharmacol. Rev. 54 2002 469 525
245. N. Sergeant, J.P. David, D. Champain, A. Ghestem, A. Wattez, and A. Delacourte Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease J. Neurochem. 81 2002 663 672
246. N. Sergeant, and A. Delacourte Alzheimer's disease: a true tauopathy fueled by APP dysfunction Brain Aging 4 2004 15 21
247. A. Delacourte, N. Sergeant, D. Champain, A. Wattez, C.A. Maurage, F. Lebert, F. Pasquier, and J.P. David Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease Neurology 59 2002 398 407
248. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. (Berl.) 82 1991 239 259
249. H. Braak, and E. Braak Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol. Aging 16 1995 271 282